Boston Scientific (NYSE:BSX) Updates FY 2024 Earnings Guidance

Boston Scientific (NYSE:BSX – Get Free Report) updated its FY 2024 earnings guidance on Wednesday. The company provided EPS guidance of 2.290-2.340 for the period, compared to the consensus EPS estimate of 2.250. The company issued revenue guidance of $15.8 billion-$16.1 billion, compared to the consensus revenue estimate of $15.6 billion. Boston Scientific also updated […]

Related Keywords

Boston ,Massachusetts ,United States ,John Bradley Sorenson ,Danielj Brennan ,Securities Exchange Commission ,Boston Scientific ,Boston Scientific Corporation ,Wells Fargo Company ,Citigroup ,Get Free Report ,Wells Fargo ,Moderate Buy ,Bradley Sorenson ,Exchange Commission ,Scientific Corporation ,Boston Scientific Daily ,Nyse Bsx ,Bsx ,Medical ,10113710 ,Guidance ,Earnings ,Preannouncement ,